ATE365037T1 - Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens - Google Patents

Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens

Info

Publication number
ATE365037T1
ATE365037T1 AT02700095T AT02700095T ATE365037T1 AT E365037 T1 ATE365037 T1 AT E365037T1 AT 02700095 T AT02700095 T AT 02700095T AT 02700095 T AT02700095 T AT 02700095T AT E365037 T1 ATE365037 T1 AT E365037T1
Authority
AT
Austria
Prior art keywords
bottle containing
oxaliplatin solution
containing oxaliplatin
cytostatic
activity
Prior art date
Application number
AT02700095T
Other languages
English (en)
Inventor
Houssam Ibrahim
Ross Blundell
Martin Gray
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4513891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365037(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of ATE365037T1 publication Critical patent/ATE365037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT02700095T 2001-03-02 2002-03-04 Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens ATE365037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3892001 2001-03-02

Publications (1)

Publication Number Publication Date
ATE365037T1 true ATE365037T1 (de) 2007-07-15

Family

ID=4513891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700095T ATE365037T1 (de) 2001-03-02 2002-03-04 Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens

Country Status (10)

Country Link
US (2) US20040220078A1 (de)
EP (1) EP1368022B1 (de)
AT (1) ATE365037T1 (de)
DE (2) DE60220766T2 (de)
DK (1) DK1368022T3 (de)
ES (1) ES2287238T3 (de)
FI (1) FI7753U1 (de)
PT (1) PT1368022E (de)
SI (1) SI1368022T1 (de)
WO (1) WO2002069959A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
RU2372089C2 (ru) * 2007-12-26 2009-11-10 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМУ Росздрава) Способ лечения больных колоректальным раком с метастазами в печень
CA2953350C (en) 2014-06-23 2019-11-26 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
BR112018000254A2 (pt) 2015-07-07 2018-09-04 H Lundbeck As inibidores de pde9 com cadeia principal de imidazotriazinona e cadeia principal de imidazopirazinona para o tratamento de doenças periféricas
AU2017292650A1 (en) 2016-07-06 2018-12-13 H. Lundbeck A/S PDE9 inhibitors for treatment of peripheral diseases
SI3630772T1 (sl) 2017-05-26 2024-05-31 Cardurion Pharmaceuticals, Inc., Postopki izdelave in uporabe zaviralcev pde9
EP3801526B1 (de) 2018-05-25 2023-12-27 Imara Inc. Monohydrat und kristalline formen von 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-on
CN112996512B (zh) 2018-08-31 2025-01-03 卡都瑞恩医药公司 用于治疗镰状细胞病的pde9抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566600A (en) * 1984-07-05 1986-01-28 Owens-Illinois, Inc. Plastic container
CA1232215A (en) * 1984-10-23 1988-02-02 Maud Frizon Sphereoidal bottle with stopper
JP3547755B2 (ja) * 1994-08-08 2004-07-28 デビオファーム・エス・アー オキサリプラティヌムの医薬的に安定な製剤
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
US6866857B1 (en) * 1998-10-14 2005-03-15 Debiopharm S.A. Oxalipatinum preparation packaging

Also Published As

Publication number Publication date
US20080108697A1 (en) 2008-05-08
DE60220766D1 (de) 2007-08-02
US20040220078A1 (en) 2004-11-04
DE20221679U1 (de) 2006-11-23
DK1368022T3 (da) 2007-10-01
PT1368022E (pt) 2007-10-01
SI1368022T1 (sl) 2007-10-31
FI7753U1 (fi) 2008-01-30
FIU20070189U0 (fi) 2007-05-07
DE60220766T2 (de) 2008-03-06
WO2002069959A1 (fr) 2002-09-12
ES2287238T3 (es) 2007-12-16
EP1368022A1 (de) 2003-12-10
EP1368022B1 (de) 2007-06-20

Similar Documents

Publication Publication Date Title
FI7753U1 (fi) Laite oksaliplatiiniliuoksen pakkaamiseksi
DE60232017D1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
UY26704A1 (es) Nueva composición farmacéutica
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
MEP8209A (en) Modified factor viii
PT1411118E (pt) Inibidores da proliferação celular contendo um anticorpo anti-glipicano 3
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
ATE387190T1 (de) Pharmazeutische zusammensetzungen mit metformin und glibenclamid zur behandlung von diabetes mellitus typ ii
PT92838A (pt) Dispensing devices powered by hydrogel
DE60204225D1 (de) Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas
IL152804A0 (en) Methods for refolding proteins containing free cysteine residues
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
NO20025355D0 (no) Farmasöytisk preparat som omfatter en faktor VIIa og en faktor XIII
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
ATE458057T1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
ATE333290T1 (de) Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
BRPI0410679A (pt) fórmulas de proteìna lìquida estabilizada em conteiners farmacêuticos cobertos
ATE156014T1 (de) Pharmazeutische zusammensetzung zur intranasalen verabreichung von hydroxocobalamin
WO2003012050A3 (en) Mitochondrial genome replenishment
BR0213298A (pt) formulações com alta concentração de proteìna e processo de fabricação
MXPA03010861A (es) COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO TRANSESTRUCTURADO Y ACTIVADO.
DE50212548D1 (de) Nicht-neurotoxische plasminogen aktivierende faktoren zur behandlung von schlaganfall
SE0103276D0 (sv) Anordning för administrering av salva till en hudyta

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368022

Country of ref document: EP

RZN Patent revoked